TY - JOUR T1 - Microinterventional endocapsular nucleus disassembly: novel technique and results of first-in-human randomised controlled study JF - British Journal of Ophthalmology JO - Br J Ophthalmol SP - 176 LP - 180 DO - 10.1136/bjophthalmol-2017-311766 VL - 103 IS - 2 AU - Tsontcho Ianchulev AU - David F Chang AU - Edward Koo AU - Susan MacDonald AU - Ernesto Calvo AU - Farrell Toby Tyson AU - Andrea Vasquez AU - Iqbal Ike K Ahmed Y1 - 2019/02/01 UR - http://bjo.bmj.com/content/103/2/176.abstract N2 - Aim To assess the safety and efficacy of microinterventional endocapsular nuclear fragmentation in moderate to severe cataracts.Methods This was a prospective single-masked multisurgeon interventional randomised controlled trial (ClinicalTrials.gov NCT02843594) where 101 eyes of 101 subjects with grade 3‒4+ nuclear cataracts were randomised to torsional phacoemulsification alone (controls) or torsional phacoemulsification with adjunctive endocapsular nuclear fragmentation using a manual microinterventional nitinol filament loop device (miLOOP group). Outcome measures were phacoemulsification efficiency as measured by ultrasound energy (cumulative dispersed energy (CDE) units) and fluidics requirements (total irrigation fluid used) as well as incidence of intraoperative and postoperative complications.Results Only high-grade advanced cataracts were enrolled with more than 85% of eyes with baseline best corrected visual acuity (BCVA) of 20/200 or worse in either group. Mean CDE was 53% higher in controls (32.8±24.9 vs 21.4±13.1 with miLOOP assistance) (p=0.004). Endothelial cell loss after surgery was low and similar between groups (7‒8%, p=0.561) One-month BCVA averaged 20/27 Snellen in miLOOP eyes and 20/24 in controls. No direct complications were caused by the miLOOP. In two cases, capsular tears occurred during IOL implantation and in all remaining cases during phacoemulsification, with none occurring during the miLOOP nucleus disassembly part of the procedure.Conclusions Microinterventional endocapsular fragmentation with the manual, disposable miLOOP device achieved consistent, ultrasound-free, full-thickness nucleus disassembly and significantly improved overall phaco efficiency in advanced cataracts.Trial registration number NCT02843594 ER -